News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
83 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (8)
2 (146)
3 (83)
4 (7)
5 (215)
6 (50)
7 (4)
8 (8)
9 (162)
10 (176)
11 (140)
12 (138)
13 (79)
14 (3)
15 (2)
16 (148)
17 (198)
18 (151)
19 (189)
20 (83)
21 (5)
22 (6)
23 (133)
24 (183)
25 (184)
26 (185)
27 (83)
28 (1)
29 (3)
30 (152)
31 (162)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Cowen Research Report: Ignore Equity Analysts in Terms of Biotech Stocks
Cowen Research’s biotech team published a recent report and concluded that investors would have better luck ignoring—or even doing the complete opposite—of what equity analysts advise.
July 3, 2018
·
2 min read
·
Mark Terry
Deals
Catalent Flexes M&A Muscle, Acquires Juniper Pharmaceuticals
Shares of Juniper Pharmaceuticals have soared more than 31 percent in premarket trading after the company announced it will be acquired by drug delivery company Catalent, Inc. in a deal with a total equity value of approximately $139.6 million.
July 3, 2018
·
2 min read
·
Alex Keown
Pharm Country
Top 10 Stories of the First Half of 2018
It’s hard to believe 2018 is half over. There have been plenty of interesting and important stories in the biopharma space this year. Here’s a look at our top 10 stories so far, counting down from 10 to the number one story.
July 3, 2018
·
5 min read
·
Mark Terry
BioMidwest
Projections Made for 5 Biggest Pharma Products in 2024
It’s time for some pharmaceutical prognostication. EvaluatePharma released its forward-looking report to 2024 that includes predictions of the best-selling prescription drugs.
July 3, 2018
·
2 min read
·
Alex Keown
Pharm Country
Pfizer Raises Prices of 40 Drugs, Some by Nearly 10%
The president’s predictions for lower drug prices fell on deaf ears at pharma giant Pfizer as it was reported that the company increased the price of 40 of its most popularly-prescribed medications by nearly 10 percent.
July 3, 2018
·
3 min read
·
Alex Keown
Business
Five Biotech Startups Tapped for MassCONNECT Summer Mentorship Program
Five startups have been tapped to join the MassCONNECT Summer Mentorship, a mentoring program provided through MASSBio. The startups were selected as representatives of “the unbelievable innovation spinning out of academia in Massachusetts.”
July 3, 2018
·
3 min read
·
Alex Keown
BioMidwest
Iowa State University Biotechnology Outreach Program Offers STEM Training to State Educators
As part of its effort to promote STEM research in the state of Iowa, the Biotechnology Outreach Education Center, part of Iowa State’s Office of Biotechnology, hosts workshops to train educators and “boost biotech in the classroom.”
July 3, 2018
·
3 min read
·
Alex Keown
Business
Novartis Walks Away from 2015 Aveo’s Antibody Agreement
Shares of Aveo are falling this morning after the company revealed Novartis has walked away from its development deal for the company’s proprietary antibody AV-380, as well as other antibodies that inhibit Growth Differentiation Factor 15.
July 3, 2018
·
2 min read
·
Alex Keown
Deals
More than $100 Billion Spent on M&A in the First 6 Months of 2018
So far during the first six months of the year, more than $100 billion has been spent on a myriad of acquisitions across the pharma and biotech industries.
July 3, 2018
·
6 min read
·
Alex Keown
Business
TRIGR Therapeutics Licenses Oncology Asset from ABL Bio in $554.3 Million-Plus Deal
TRIGR Therapeutics, based in Irvine California, signed a deal with South Korean company ABL Bio Corporation. TIRGR is licensing the global commercial rights to ABL Bio’s pipeline of antibodies to treat cancer.
July 3, 2018
·
2 min read
·
Mark Terry
1 of 9
Next